HIV Clinical Research Unit Operated by the USF Health Division of Infectious Disease & International Medicine at Hillsborough County Health Department
Research that makes a difference
To Enroll 813.307.8067 or Register for Updates
Your Subtitle text
Welcome
Opportunities for better medical treatment don’t just happen. These opportunities are created by
careful clinical research into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. Synergistically combining our efforts with state of the art clinical facilities for HIV primary care at the Specialty Care Center (which even includes a dental care program) our patients receive the highest quality care possible.
careful clinical research into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. Synergistically combining our efforts with state of the art clinical facilities for HIV primary care at the Specialty Care Center (which even includes a dental care program) our patients receive the highest quality care possible. The HIV Clinical Research Unit serves as an exceptional study and trial environment with a highly qualified staff and an excellent performance record.
For both patients and physicians, it represents an opportunity to obtain access to innovative experimental therapies before they are widely available. We are committed to delivering the best medical research to patients: it is our mission to serve and heal.
Charurut Somboonwit, MD, FACP
Assistant Professor of Medicine, Division of Infectious Disease & International Medicine, University of South Florida
Director, Communicable Diseases, Hillsborough County Health Department
About Us
The Clinical Research Unit was established in 1995 by Dr. Jeffrey Nadler through a partnership with the University of South Florida
Our patients gain:
- Early access to new drugs and laboratory monitoring tests
- More intensive disease management
- Access to highly qualified and experienced specialists
- Our physicians dedicate time to fully educate patients on advancements in HIV care
For the past 14 years, the physicians and staff of the USF Division of Infectious Disease have been involved in bringing 24 HIV medications to market, including nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside/non-nucleotide reverse transcriptase inhibitors, protease inhibitors, entry inhibitors, and integrase inhibitors. We accept unfunded patients, Medicare, Medicaid, Hillsborough Heathcare and many commercial plans.
